Application of an Insulin Analogue in Six Hypoglycemia-Prone Hemodialysis Patients with Type 2 Diabetes |
Kim, Gyung Eun
(Department of Internal Medicine, Inha University School of Medicine)
Hong, Seong Bin (Department of Internal Medicine, Inha University School of Medicine) Han, Ju Young (Department of Internal Medicine, Inha University School of Medicine) Jang, Ji Hun (Department of Internal Medicine, Inha University School of Medicine) Yang, Dong Hyuk (Department of Internal Medicine, Inha University School of Medicine) Lee, Seoung Woo (Department of Internal Medicine, Inha University School of Medicine) Song, Joon Ho (Department of Internal Medicine, Inha University School of Medicine) |
1 | Dirks JH, de Zeeuw D, Agarwal SK, et al. Prevention of chronic kidney and vascular disease: toward global health equity: the Bellagio 2004 declaration. Kidney Int Suppl 2005;(98):S1-S6. |
2 | Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047. DOI ScienceOn |
3 | O'Toole SM, Fan SL, Yaqoob MM, Chowdhury TA. Managing diabetes in dialysis patients. Postgrad Med J 2012;88:160-166. DOI ScienceOn |
4 | American Diabetes Association. Standards of medical care in diabetes: 2012. Diabetes Care 2012;35(Suppl 1):S11-S63. |
5 | Gerich JE, Meyer C, Woerle HJ, Stumvoll M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 2001;24:382-391. DOI ScienceOn |
6 | Jackson MA, Holland MR, Nicholas J, Lodwick R, Forster D, Macdonald IA. Hemodialysis-induced hypoglycemia in diabetic patients. Clin Nephrol 2000;54:30-34. |
7 | Jackson MA, Holland MR, Nicholas J, et al. Occult hypoglycemia caused by hemodialysis. Clin Nephrol 1999;51:242-247. |
8 | Hirsch IB. Insulin analogues. N Engl J Med 2005;352:174-183. DOI ScienceOn |
9 | Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 2004;17:365-370. DOI ScienceOn |
10 | Sobngwi E, Enoru S, Ashuntantang G, et al. Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis. Diabetes Care 2010;33:1409-1412. DOI ScienceOn |
11 | Lipska KJ, Kosiborod M. Hypoglycemia and adverse outcomes: marker or mediator? Rev Cardiovasc Med 2011;12:132-135. |
12 | Ceriello A, Ihnat MA. 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med 201027:862-867. |